
A G Barr Plc
AG Barr Plc (LON: BAG) is a FTSE All-Share listed manufacturer and seller of aerated water and soft drinks. The Company’s brands include RN-BRU, Rubicon and Funkin.
In August 2021, the Company will release its next trading update.
Rationale for Valuation – Speculative Buy at GBX 537.00
Key Risks
AGM Trading Update (as on 28 May 2021)
One Year Share Price Chart

(Research Done by the Kalkine Group)
Valuation Methodology: Price/Earnings Approach (FY22E) (Illustrative)

Conclusion
The Company entered the financial year 2022 with an exciting innovation pipeline and resilient brand performance, supported by continuous investment in brand building. In the recent update, the Company stated that trading was in line with the Board's expectations. Meanwhile, the Company closed the financial year 2021 in strong financial health. BAG also stated that it had a clear intention to recommence dividend payments. BAG further developed the Energy market strategy and is focused on utilising digital platforms for changing market dynamics. The business has stayed strongly cash generative throughout the year. Overall, the Company is confident to make further progress in the coming year. The stock made a 52-week low and high of GBX 369.00 and GBX 550.00, respectively. On the technical chart, the next important support level is at GBX 469.00.
Based on the strong balance sheet and support from the valuation as done using the above method, we have given a “Speculative Buy” recommendation on AG Barr Plc at the current price of GBX 537.00 (as on 3 June 2021 at 2:20 PM GMT) with a lower double-digit upside potential based on 26.39x Price/NTM Earnings (approx.) on FY22E earnings per share (approx.).
Batm Advanced Communications Ltd
Batm Advanced Communications Ltd (LON: BVC) is engaged in research and development of data communication products for medical laboratory systems.
Rationale for Valuation – Speculative Buy at GBX 81.90
Key Risks
Recent News
On 18 May 2021, BVC started the delivery of two Covid-19 tests to Italy. The Italian public health authorities and the Olympics committee issued these two saliva-based RT-PCR test and rapid lateral flow test.
Financial Highlights (for the year ended 31 December 2020 (FY20), as on 19 April 2021)

(Source: Company Website)
One Year Share Price Chart

(Research Done by the Kalkine Group)
Valuation Methodology: Price/Earnings (FY21E) (Illustrative)

Conclusion
The Company expects the Bio-Medical Division to stay the largest contributor to 2021 revenues, supported by the strong order book. In 2021, it expects revenue growth from continuing operations and to achieve further improvement in gross margin. BVC entered the year 2021 with strong solutions demand in both of the divisions. However, the Company’s operations were impacted by the uncertainty related to the covid-19 crisis.
Meanwhile, the Company has shown robust financial performance in the financial year 2020. The Company has also established infrastructure to expand the business into new markets. The stock made a 52-week low and high of GBX 78.40 and GBX 150.50, respectively. On the technical chart, the next important support level is at GBX 67.00.
Based on the highly successful year, strong strategic and financial progress, and support from the valuation as done using the above method, we have given a “Speculative Buy” recommendation on Batm Advanced Communications Ltd at the current price of GBX 81.90 (as on 3 June 2021 at 1:45 PM GMT) with a lower double-digit upside potential based on 46.62x Price/ Earnings (FY21E) (approx.) on FY21E earnings per share (approx.).
*All forecasted figures and Peer/Industry information have been taken from Refinitiv.
*Dividend Yield may vary as per the stock price movement.
*Depending upon the risk tolerance, investors may consider unwinding their positions in a respective stock once the estimated target price is reached or if the price closes below the support level (indicative stop-loss price).
Disclaimer
References to ‘Kalkine’, ‘we’, ‘our’ and ‘us’ refer to Kalkine Limited.
This website is a service of Kalkine Limited. Kalkine Limited is a private limited company, incorporated in England and Wales with registration number 07903332. Kalkine Limited is authorised and regulated by the Financial Conduct Authority under reference number 579414.
The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. No advice or information, whether oral or written, obtained by you from Kalkine or through or from the service shall create any warranty not expressly stated. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation.
Kalkine does not offer financial advice based upon your personal financial situation or goals, and we shall NOT be held liable for any investment or trading losses you may incur by using the opinions expressed in our publications, market updates, news alerts and corporate profiles. Kalkine does not intend to exclude any liability which it is not permitted to exclude under applicable law or regulation. Kalkine’s non-personalised advice does not in any way endorse or recommend individuals, investment products or services for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a professional authorised financial planner and adviser. You should be aware that the value of any investment and the income from it can go down as well as up and you may not get back the amount invested.
Past performance is not a reliable indicator of future performance.